Bank of New York Mellon’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $133M | Sell |
629,339
-26,622
| -4% | -$5.22M | 0.02% | 546 |
|
|
2026
Q1 | $129M | Sell |
655,961
-14,780
| -2% | -$2.87M | 0.02% | 534 |
|
|
2025
Q4 | $116M | Sell |
670,741
-150,839
| -18% | -$27.5M | 0.02% | 568 |
|
|
2025
Q3 | $157M | Sell |
821,580
-18
| -0% | -$3.19K | 0.03% | 450 |
|
|
2025
Q2 | $148M | Sell |
821,598
-47,751
| -5% | -$8.29M | 0.03% | 454 |
|
|
2025
Q1 | $147M | Sell |
869,349
-12,415
| -1% | -$2.04M | 0.03% | 456 |
|
|
2024
Q4 | $133M | Buy |
881,764
+113,956
| +15% | +$17.7M | 0.02% | 524 |
|
|
2024
Q3 | $119M | Sell |
767,808
-23,152
| -3% | -$3.46M | 0.02% | 571 |
|
|
2024
Q2 | $108M | Sell |
790,960
-14,347
| -2% | -$1.96M | 0.02% | 603 |
|
|
2024
Q1 | $107M | Sell |
805,307
-33,961
| -4% | -$4.41M | 0.02% | 623 |
|
|
2023
Q4 | $116M | Sell |
839,268
-27,965
| -3% | -$3.68M | 0.02% | 586 |
|
|
2023
Q3 | $106M | Sell |
867,233
-31,522
| -4% | -$4.2M | 0.02% | 586 |
|
|
2023
Q2 | $126M | Sell |
898,755
-19,990
| -2% | -$2.76M | 0.03% | 539 |
|
|
2023
Q1 | $130M | Sell |
918,745
-38,688
| -4% | -$5.54M | 0.03% | 510 |
|
|
2022
Q4 | $150M | Sell |
957,433
-176,020
| -16% | -$25.3M | 0.03% | 448 |
|
|
2022
Q3 | $139M | Sell |
1,133,453
-116,503
| -9% | -$15.3M | 0.03% | 467 |
|
|
2022
Q2 | $166M | Buy |
1,249,956
+16,899
| +1% | +$2.3M | 0.04% | 420 |
|
|
2022
Q1 | $169M | Buy |
1,233,057
+56,581
| +5% | +$7.89M | 0.03% | 453 |
|
|
2021
Q4 | $204M | Sell |
1,176,476
-28,009
| -2% | -$4.26M | 0.04% | 420 |
|
|
2021
Q3 | $175M | Sell |
1,204,485
-28,870
| -2% | -$4.22M | 0.03% | 456 |
|
|
2021
Q2 | $163M | Buy |
1,233,355
+86,065
| +8% | +$11.3M | 0.03% | 480 |
|
|
2021
Q1 | $147M | Buy |
1,147,290
+4,124
| +0.4% | +$508K | 0.03% | 522 |
|
|
2020
Q4 | $136M | Buy |
1,143,166
+48,888
| +4% | +$5.96M | 0.03% | 513 |
|
|
2020
Q3 | $125M | Buy |
1,094,278
+35,543
| +3% | +$4.2M | 0.03% | 483 |
|
|
2020
Q2 | $121M | Buy |
1,058,735
+6,863
| +0.7% | +$728K | 0.03% | 464 |
|
|
2020
Q1 | $84.5M | Buy |
1,051,872
+3,376
| +0.3% | +$350K | 0.03% | 533 |
|
|
2019
Q4 | $112M | Sell |
1,048,496
-334,256
| -24% | -$34.9M | 0.03% | 554 |
|
|
2019
Q3 | $148M | Sell |
1,382,752
-13,542
| -1% | -$1.39M | 0.04% | 413 |
|
|
2019
Q2 | $142M | Buy |
1,396,294
+10,980
| +0.8% | +$1.06M | 0.04% | 449 |
|
|
2019
Q1 | $125M | Sell |
1,385,314
-379,197
| -21% | -$32.9M | 0.03% | 479 |
|
|
2018
Q4 | $147M | Sell |
1,764,511
-113,355
| -6% | -$10.6M | 0.05% | 378 |
|
|
2018
Q3 | $203M | Buy |
1,877,866
+96,493
| +5% | +$10.6M | 0.05% | 348 |
|
|
2018
Q2 | $196M | Buy |
1,781,373
+648,706
| +57% | +$67.6M | 0.05% | 346 |
|
|
2018
Q1 | $114M | Sell |
1,132,667
-57,069
| -5% | -$5.84M | 0.03% | 529 |
|
|
2017
Q4 | $117M | Buy |
1,189,736
+29,319
| +3% | +$2.78M | 0.03% | 551 |
|
|
2017
Q3 | $109M | Sell |
1,160,417
-9,858
| -0.8% | -$1.05M | 0.03% | 557 |
|
|
2017
Q2 | $130M | Sell |
1,170,275
-318,066
| -21% | -$33.6M | 0.04% | 474 |
|
|
2017
Q1 | $146M | Buy |
1,488,341
+270,661
| +22% | +$25.8M | 0.04% | 446 |
|
|
2016
Q4 | $112M | Sell |
1,217,680
-263,310
| -18% | -$22.7M | 0.03% | 520 |
|
|
2016
Q3 | $125M | Buy |
1,480,990
+952
| +0.1% | +$80K | 0.04% | 456 |
|
|
2016
Q2 | $120M | Sell |
1,480,038
-50,686
| -3% | -$3.86M | 0.04% | 458 |
|
|
2016
Q1 | $109M | Sell |
1,530,724
-43,011
| -3% | -$2.88M | 0.03% | 501 |
|
|
2015
Q4 | $112M | Sell |
1,573,735
-73,898
| -4% | -$4.97M | 0.03% | 485 |
|
|
2015
Q3 | $101M | Sell |
1,647,633
-49,826
| -3% | -$3.48M | 0.03% | 530 |
|
|
2015
Q2 | $123M | Sell |
1,697,459
-115,249
| -6% | -$8.51M | 0.03% | 491 |
|
|
2015
Q1 | $139M | Buy |
1,812,708
+30,686
| +2% | +$2.2M | 0.04% | 466 |
|
|
2014
Q4 | $120M | Sell |
1,782,022
-804,626
| -31% | -$50.8M | 0.03% | 527 |
|
|
2014
Q3 | $157M | Buy |
2,586,648
+80,394
| +3% | +$4.95M | 0.04% | 423 |
|
|
2014
Q2 | $147M | Buy |
2,506,254
+60,639
| +2% | +$3.55M | 0.04% | 456 |
|
|
2014
Q1 | $142M | Buy |
2,445,615
+29,114
| +1% | +$1.56M | 0.04% | 457 |
|
|
2013
Q4 | $129M | Buy |
2,416,501
+597,723
| +33% | +$35.5M | 0.04% | 490 |
|
|
2013
Q3 | $112M | Sell |
1,818,778
-89,803
| -5% | -$5.38M | 0.03% | 507 |
|
|
2013
Q2 | $116M | Buy |
+1,908,581
| New | +$114M | 0.04% | 481 |
|
Other funds holding DGX
DSA
Bank of New York Mellon's DGX Position: Q2 2026 in Review
Bank of New York Mellon reduced its Quest Diagnostics (DGX) stake by 4.1% in Q2 2026, selling an estimated $5.22M and leaving 629,339 shares worth $133M. The position accounts for 0.02% of the portfolio, ranked #546.
Bank of New York Mellon first reported a position in DGX in Q2 2013 and has held it in 53 quarters since. The position peaked at $204M in Q4 2021. 774 funds tracked by Wall St. Rank hold DGX as of Q2 2026.
- Bank of New York Mellon held 629,339 shares of Quest Diagnostics worth $133M as of Q2 2026.
- Bank of New York Mellon sold 26,622 Quest Diagnostics shares in Q2 2026, an estimated $5.22M.
- Quest Diagnostics made up 0.02% of Bank of New York Mellon's portfolio in Q2 2026, its #546 holding.
- Bank of New York Mellon first reported a position in Quest Diagnostics in Q2 2013 and has held it in 53 quarters since.
- Bank of New York Mellon's Quest Diagnostics position peaked at $204M in Q4 2021.
- 774 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.
Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.